Large-Scale Nucleotide Optimization of Simian Immunodeficiency Virus Reduces Its Capacity To Stimulate Type I Interferon In Vitro

ABSTRACT Lentiviral RNA genomes present a strong bias in their nucleotide composition with extremely high frequencies of A nucleotide in human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIV). Based on the observation that human optimization of RNA virus gene fragments may abolish their ability to stimulate the type I interferon (IFN-I) response, we identified the most biased sequences along the SIV genome and showed that they are the most potent IFN-I stimulators. With the aim of designing an attenuated SIV genome based on a reduced capacity to activate the IFN-I response, we synthesized artificial SIV genomes whose biased sequences were optimized toward macaque average nucleotide composition without altering their regulatory elements or amino acid sequences. A synthetic SIV optimized with 169 synonymous mutations in gag and pol genes showed a 100-fold decrease in replicative capacity. Interestingly, a synthetic SIV optimized with 70 synonymous mutations in pol had a normal replicative capacity. Its ability to stimulate IFN-I was reduced when infected cells were cocultured with reporter cells. IFN regulatory factor 3 (IRF3) transcription factor was required for IFN-I stimulation, implicating cytosolic sensors in the detection of SIV-biased RNA in infected cells. No reversion of introduced mutations was observed for either of the optimized viruses after 10 serial passages. In conclusion, we have designed large-scale nucleotide-modified SIVs that may display attenuated pathogenic potential. IMPORTANCE In this study, we synthesized artificial SIV genomes in which the most hyperbiased sequences were optimized to bring them closer to the nucleotide composition of the macaque SIV host. Interestingly, we generated a stable synthetic SIV optimized with 70 synonymous mutations in pol gene, which had a normal replicative capacity but a reduced ability to stimulate type I IFN. This demonstrates the possibility to rationally change viral nucleotide composition to design replicative and genetically stable lentiviruses with attenuated pathogenic potentials.

[1]  D. Barouch Rational design of gene‐based vaccines , 2006, The Journal of pathology.

[2]  E. Lesnik,et al.  Relative thermodynamic stability of DNA, RNA, and DNA:RNA hybrid duplexes: relationship with base composition and structure. , 1995, Biochemistry.

[3]  Arnold J Levine,et al.  Tissue-specific codon usage and the expression of human genes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[4]  P. Luciw,et al.  Simian immunodeficiency virus (SIVmac) exhibits complex splicing for tat, rev, and env mRNA. , 1991, Virology.

[5]  P. Mangeot,et al.  Development of Minimal Lentivirus Vectors Derived from Simian Immunodeficiency Virus (SIVmac251) and Their Use for Gene Transfer into Human Dendritic Cells , 2000, Journal of Virology.

[6]  Osamu Takeuchi,et al.  IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction , 2005, Nature Immunology.

[7]  F. Mustafa,et al.  Sequences within the gag gene of feline immunodeficiency virus (FIV) are important for efficient RNA encapsidation. , 2003, Virus research.

[8]  J. Kagan,et al.  Intracellular pathogen detection by RIG-I-like receptors. , 2013, Advances in immunology.

[9]  P. Auewarakul Composition bias and genome polarity of RNA viruses , 2004, Virus Research.

[10]  Philip R. Johnson,et al.  HIV vaccine design: insights from live attenuated SIV vaccines , 2005, Nature Immunology.

[11]  S. Le,et al.  The A-rich RNA sequences of HIV-1 pol are important for the synthesis of viral cDNA , 2008, Nucleic acids research.

[12]  A. Baum,et al.  Differential recognition of viral RNA by RIG-I , 2011, Virulence.

[13]  B. Berkhout,et al.  The biased nucleotide composition of the HIV genome: a constant factor in a highly variable virus , 2012, Retrovirology.

[14]  P. Vidalain,et al.  Differential Regulation of Type I Interferon and Epidermal Growth Factor Pathways by a Human Respirovirus Virulence Factor , 2009, PLoS pathogens.

[15]  G. Kochs,et al.  The Mx GTPase family of interferon-induced antiviral proteins. , 2007, Microbes and infection.

[16]  F. Tangy,et al.  The Biased Nucleotide Composition of HIV-1 Triggers Type I Interferon Response and Correlates with Subtype D Increased Pathogenicity , 2012, PloS one.

[17]  J. Lifson,et al.  Downregulation of Robust Acute Type I Interferon Responses Distinguishes Nonpathogenic Simian Immunodeficiency Virus (SIV) Infection of Natural Hosts from Pathogenic SIV Infection of Rhesus Macaques , 2010, Journal of Virology.

[18]  J. M. Comeron,et al.  Selective and Mutational Patterns Associated With Gene Expression in Humans , 2004, Genetics.

[19]  Z. Zhai,et al.  VISA is an adapter protein required for virus-triggered IFN-beta signaling. , 2005, Molecular cell.

[20]  S. Cusack,et al.  Structural Basis for the Activation of Innate Immune Pattern-Recognition Receptor RIG-I by Viral RNA , 2011, Cell.

[21]  M. Si-Tahar,et al.  Innate Sensing of HIV-Infected Cells , 2011, PLoS pathogens.

[22]  Vishvanath Nene,et al.  Faculty Opinions recommendation of Live attenuated influenza virus vaccines by computer-aided rational design. , 2010 .

[23]  D. Weiner,et al.  DNA vaccines: developing new strategies to enhance immune responses , 2008, Immunologic research.

[24]  T. Monath,et al.  Viral vectors for malaria vaccine development , 2006, Vaccine.

[25]  S. Arya,et al.  Human immunodeficiency virus type 2 long terminal repeat: analysis of regulatory elements. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[26]  B. Clotet,et al.  Changes in codon-pair bias of human immunodeficiency virus type 1 have profound effects on virus replication in cell culture , 2013, Retrovirology.

[27]  A. Bowie,et al.  Activation of host pattern recognition receptors by viruses. , 2010, Current opinion in microbiology.

[28]  J. Plotkin,et al.  Synonymous but not the same: the causes and consequences of codon bias , 2011, Nature Reviews Genetics.

[29]  S. Le,et al.  A highly conserved RNA folding region coincident with the Rev response element of primate immunodeficiency viruses. , 1990, Nucleic acids research.

[30]  Zhijian J. Chen,et al.  Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. , 2005, Cell.

[31]  F. Barré-Sinoussi,et al.  Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. , 2009, The Journal of clinical investigation.

[32]  Jean Salamero,et al.  HIV Coreceptor Downregulation as Antiviral Principle: SDF-1α–dependent Internalization of the Chemokine Receptor CXCR4 Contributes to Inhibition of HIV Replication , 1997, The Journal of experimental medicine.

[33]  G. Lutfalla,et al.  Domains of interaction between alpha interferon and its receptor components. , 1994, Journal of molecular biology.

[34]  W. Robinson,et al.  Disruption of the putative splice acceptor site for SIV(mac239)Vif reveals tight control of SIV splicing and impaired replication in Vif non-permissive cells. , 2005, Virology.

[35]  M. Katze,et al.  Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. , 1998, Pharmacology & therapeutics.

[36]  M. Wainberg,et al.  Recovery of fitness of a live attenuated simian immunodeficiency virus through compensation in both the coding and non-coding regions of the viral genome , 2007, Retrovirology.

[37]  Michael Gale,et al.  Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA , 2008, Nature.

[38]  T. Walz,et al.  Structural Basis for dsRNA Recognition, Filament Formation, and Antiviral Signal Activation by MDA5 , 2013, Cell.

[39]  H. Akashi,et al.  Translational selection and molecular evolution. , 1998, Current opinion in genetics & development.

[40]  M. Gale,et al.  Structural basis of RNA recognition and activation by innate immune receptor RIG-I , 2011, Nature.

[41]  M. Gouy,et al.  Codon catalog usage and the genome hypothesis. , 1980, Nucleic acids research.

[42]  Z. Zhai,et al.  VISA Is an Adapter Protein Required for Virus-Triggered IFN-β Signaling , 2005 .

[43]  Andrew S. Kohlway,et al.  Structural Insights into RNA Recognition by RIG-I , 2011, Cell.

[44]  R. Desrosiers,et al.  The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. , 1990, AIDS research and human retroviruses.

[45]  T. Ikemura Codon usage and tRNA content in unicellular and multicellular organisms. , 1985, Molecular biology and evolution.

[46]  Y. Liu,et al.  Cis-acting RNA elements in human and animal plus-strand RNA viruses , 2009, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms.

[47]  Kristen K. Dang,et al.  Architecture and Secondary Structure of an Entire HIV-1 RNA Genome , 2009, Nature.

[48]  R. Silverman,et al.  Small self-RNA generated by RNase L amplifies antiviral innate immunity , 2007, Nature.

[49]  M. Malim,et al.  APOBEC-Mediated Editing of Viral RNA , 2004, Science.

[50]  A. Vincent,et al.  Modulation of Poliovirus Replicative Fitness in HeLa Cells by Deoptimization of Synonymous Codon Usage in the Capsid Region , 2006, Journal of Virology.

[51]  B. Berkhout,et al.  The unusual nucleotide content of the HIV RNA genome results in a biased amino acid composition of HIV proteins. , 1994, Nucleic acids research.

[52]  M. Malim,et al.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein , 2002, Nature.

[53]  J. R. Coleman,et al.  Virus Attenuation by Genome-Scale Changes in Codon Pair Bias , 2008, Science.

[54]  E. Holmes What Does Virus Evolution Tell Us about Virus Origins? , 2011, Journal of Virology.

[55]  C. Coch,et al.  Approaching the RNA ligand for RIG‐I? , 2009, Immunological reviews.

[56]  Yves Moreau,et al.  Estimating the Relative Contribution of dNTP Pool Imbalance and APOBEC3G/3F Editing to HIV Evolution In Vivo , 2007, J. Comput. Biol..

[57]  D. W. Staple,et al.  Programmed ribosomal frameshifting in SIV is induced by a highly structured RNA stem-loop. , 2007, Journal of molecular biology.

[58]  Ralf Bartenschlager,et al.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.

[59]  G. W. Hatfield,et al.  Nonrandom utilization of codon pairs in Escherichia coli. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[60]  Elmar Nurmemmedov,et al.  Biophysics of viral infectivity: matching genome length with capsid size , 2007, Quarterly Reviews of Biophysics.

[61]  J. Rehwinkel,et al.  RIGorous Detection: Exposing Virus Through RNA Sensing , 2010, Science.

[62]  B. Berkhout,et al.  Codon and amino acid usage in retroviral genomes is consistent with virus-specific nucleotide pressure. , 2002, AIDS research and human retroviruses.

[63]  S. Govindarajan,et al.  Codon bias and heterologous protein expression. , 2004, Trends in biotechnology.

[64]  A. Iwasaki A virological view of innate immune recognition. , 2012, Annual review of microbiology.

[65]  S. Goodbourn,et al.  The NPro Product of Bovine Viral Diarrhea Virus Inhibits DNA Binding by Interferon Regulatory Factor 3 and Targets It for Proteasomal Degradation , 2006, Journal of Virology.

[66]  Q. Sattentau,et al.  Avoiding the void: cell-to-cell spread of human viruses , 2008, Nature Reviews Microbiology.

[67]  B. Berkhout,et al.  The A-nucleotide preference of HIV-1 in the context of its structured RNA genome , 2013, RNA biology.

[68]  G. Silvestri AIDS pathogenesis: a tale of two monkeys , 2008, Journal of medical primatology.

[69]  Zhijian J. Chen,et al.  Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3 , 2005, Cell.

[70]  M. Weitzman,et al.  Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11 , 2012, Nature.

[71]  M. Peretz,et al.  The HIV-1 Central Polypurine Tract Functions as a Second Line of Defense against APOBEC3G/F , 2010, Journal of Virology.

[72]  Steven Skiena,et al.  Reduction of the Rate of Poliovirus Protein Synthesis through Large-Scale Codon Deoptimization Causes Attenuation of Viral Virulence by Lowering Specific Infectivity , 2006, Journal of Virology.

[73]  Araxi O. Urrutia,et al.  The signature of selection mediated by expression on human genes. , 2003, Genome research.